- Home
- IMRN vs ARTW Comparison
IMRN vs ARTW Comparison
Compare IMRN & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- ARTW
- Stock Information
- Founded
- IMRN 1994
- ARTW 1956
- Country
- IMRN Australia
- ARTW United States
- Employees
- IMRN N/A
- ARTW N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- ARTW Industrial Machinery/Components
- Sector
- IMRN Health Care
- ARTW Industrials
- Exchange
- IMRN Nasdaq
- ARTW Nasdaq
- Market Cap
- IMRN 14.4M
- ARTW 12.5M
- IPO Year
- IMRN N/A
- ARTW N/A
- Fundamental
- Price
- IMRN $2.10
- ARTW $2.52
- Analyst Decision
- IMRN
- ARTW
- Analyst Count
- IMRN 0
- ARTW 0
- Target Price
- IMRN N/A
- ARTW N/A
- AVG Volume (30 Days)
- IMRN 96.3K
- ARTW 60.0K
- Earning Date
- IMRN 08-29-2025
- ARTW 10-07-2025
- Dividend Yield
- IMRN N/A
- ARTW N/A
- EPS Growth
- IMRN N/A
- ARTW N/A
- EPS
- IMRN N/A
- ARTW 0.49
- Revenue
- IMRN $4,777,422.00
- ARTW $24,079,949.00
- Revenue This Year
- IMRN N/A
- ARTW N/A
- Revenue Next Year
- IMRN N/A
- ARTW N/A
- P/E Ratio
- IMRN N/A
- ARTW $6.40
- Revenue Growth
- IMRN 48.63
- ARTW N/A
- 52 Week Low
- IMRN $1.50
- ARTW $1.43
- 52 Week High
- IMRN $2.48
- ARTW $4.71
- Technical
- Relative Strength Index (RSI)
- IMRN 50.56
- ARTW 43.32
- Support Level
- IMRN $2.10
- ARTW $2.30
- Resistance Level
- IMRN $2.24
- ARTW $2.64
- Average True Range (ATR)
- IMRN 0.12
- ARTW 0.25
- MACD
- IMRN -0.02
- ARTW -0.01
- Stochastic Oscillator
- IMRN 32.50
- ARTW 27.30
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.